Rilmazafone hydrochloride is a water-soluble benzodiazepine prodrug used mainly in Japan as a sedative-hypnotic for treating insomnia. It is inactive until metabolized by aminopeptidases in the small intestine into active benzodiazepine metabolites. It offers efficient sleep initiation with minimal muscle-relaxant effects. Its therapeutic use is listed as sleeping drugs. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Rhythmy. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 9958041.
Rilmazafone hydrochloride
| CAS No | 85815-37-8 |
|---|---|
| Molecular Formula | C21H21Cl3N6O3 |
| Molecular Weight | 511.8 g/mol |
| Synonyms | 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide;hydrochloride |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Rilmazafone hydrochloride is a water-soluble benzodiazepine prodrug used mainly in Japan as a sedative-hypnotic for treating insomnia. It is inactive until metabolized by aminopeptidases in the small intestine into active benzodiazepine metabolites.
The listed CAS number is 85815-37-8.
The listed molecular formula is C21H21Cl3N6O3.
The listed molecular weight is 511.8 g/mol.
5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide;hydrochloride.
The source lists Rhythmy.